These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1344973)

  • 1. Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer.
    Fisher B; Wickerham DL; Redmond C
    Semin Oncol; 1992 Jun; 19(3):263-77. PubMed ID: 1344973
    [No Abstract]   [Full Text] [Related]  

  • 2. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
    Sdrobolini A
    Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support.
    Leonard JP
    Curr Hematol Rep; 2003 Nov; 2(6):451-2. PubMed ID: 14561387
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-operative therapy of breast cancer: rationale for adjuvant chemotherapy.
    Butler WM
    J S C Med Assoc; 1984 Jan; 80(1):15-6. PubMed ID: 6371378
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving concepts in the systemic adjuvant treatment of breast cancer.
    Bonadonna G
    Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant therapy of breast cancer without regional metastases].
    Shparik IaV; Bilins'kiĭ BT
    Klin Khir; 1995; (5):42-6. PubMed ID: 8646633
    [No Abstract]   [Full Text] [Related]  

  • 9. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence?].
    Baldini E; Prochilo T
    Suppl Tumori; 2004; 3(4):S79-80. PubMed ID: 15206221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary results of adjuvant chemo- and chemohormonotherapy in breast cancer patients].
    Marinov D; Tsekova V; Koĭnov K; Velikova M
    Khirurgiia (Sofiia); 1988; 41(4):50-5. PubMed ID: 3199738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant chemotherapy of breast cancer].
    Chevallier B; Bastit P
    Presse Med; 1986 May; 15(18):835-8. PubMed ID: 2940539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.
    Mayers C; Panzarella T; Tannock IF
    Cancer; 2001 Jun; 91(12):2246-57. PubMed ID: 11413512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer.
    Hryniuk W
    J Natl Cancer Inst; 1999 Aug; 91(16):1425. PubMed ID: 10451457
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
    Ludwig Breast Cancer Study Group
    N Engl J Med; 1988 Sep; 319(11):677-83. PubMed ID: 2901037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in the treatment of primary breast cancer].
    Letiagin VP
    Vopr Onkol; 1998; 44(5):632-5. PubMed ID: 9884732
    [No Abstract]   [Full Text] [Related]  

  • 19. New sequential dosing regimen shows promise in node-positive breast cancer.
    Oncology (Williston Park); 1996 Apr; 10(4):552-3. PubMed ID: 8723286
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant systemic therapy for breast cancer.
    Harris DT
    Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.